SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wikman Ola)
 

Sökning: WFRF:(Wikman Ola) > Anemia and iron def...

  • Befrits, RagnarKarolinska University Hospital, Sweden (författare)

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life

  • Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

  • 2013-07-29
  • Informa Healthcare,2013
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-97439
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-97439URI
  • https://doi.org/10.3109/00365521.2013.819442DOI
  • https://lup.lub.lu.se/record/4025766URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|Vifor Pharma Nordiska AB, Kista, Sweden||
  • Objective. Iron deficiency and anemia are being increasingly recognized as a complication of inflammatory bowel disease (IBD). The aim of this study was to observe, in a non-interventional way, how Swedish gastroenterologists adhere to guidelines in IBD outpatients treated with intravenous ferric carboxymaltose (FCM), and the result of treatment. Material and methods. Altogether 394 IBD patients (Crohns disease (CD) 60%, ulcerative colitis (UC) 40%) from 14 centers were included. Group A (n = 216) was observed from November 2008 and group B (n = 178) from March 2010. Time of observation ranged from 12 to 29 months. Results. S-Ferritin (mmol/l) and transferrin saturation (T-Sat; %) were recorded at baseline in 62% and 50% in group A. Median values for Hb, ferritin and T-Sat at baseline were 111 g/l, 10 mu mol/l and 10%, respectively, and 134 g/l, 121 mmol/l and 20% after iron treatment (p andlt; 0.001 for all three parameters). Similar results were found in group B. Approximately three-quarters of all patients had only one iron infusion during the study period. Median time to reinfusion was 6 (1-25) months. Only previously described infusion reactions occurred in 27 (7%) patients. Conclusions. Adherence to European guidelines was rather poor and needs to be improved. The effect on iron parameters of intravenous FCM was significant, and resulted in a ferritin level that indicates an effect on the iron stores. The effect was mostly sustained for a year since only one-quarter of the patients were given repeated iron infusions. No unforeseen safety concerns emerged during the observation period.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Wikman, OlaSoder Sjukhuset, Sweden (författare)
  • Blomquist, LarsKarolinska University Hospital, Sweden (författare)
  • Hjortswang, HenrikÖstergötlands Läns Landsting,Linköpings universitet,Gastroenterologi och hepatologi,Hälsouniversitetet,Magtarmmedicinska kliniken(Swepub:liu)henhj44 (författare)
  • Hammarlund, PerAngelholm Hospital, Sweden (författare)
  • Bajor, AntalSahlgrens University Hospital, Sweden (författare)
  • Klintman, DanielLund University,Lunds universitet,Gastroenterologi,Forskargrupper vid Lunds universitet,Gastroenterology,Lund University Research Groups,MAS University Hospital, Sweden(Swepub:lu)kir-dkl (författare)
  • Blom, HakanSunderby Hospital, Sweden (författare)
  • Karolinska University Hospital, SwedenSoder Sjukhuset, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Scandinavian Journal of Gastroenterology: Informa Healthcare48:9, s. 1027-10320036-55211502-7708

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy